Moreover, TNAP inhibition promotes the upregulation of TP53, which attenuates migration, differentiation, and expression of collagen-related genes in TGFβ1-activated CFs. The gene discussed is TGFB1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.